日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acceptability and tolerability of long-acting injectable cabotegravir-rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial

长效注射用卡博特韦-利匹韦林在HIV-1感染青少年中的可接受性和耐受性(IMPAACT 2017/MOCHA):一项多中心、开放标签、非对照1/2期试验的48周结果

Lowenthal, Elizabeth D; Chapman, Jennifer; Baltrusaitis, Kristin; Kovic, Grace; Merchant, Sanjna; Branch, Kaleb; Tsosie, Chermiqua; Vaca, Martina Zapata; Heckman, Barbara; Van Solingen-Ristea, Rodica M; Harrington, Conn M; Yin, Dwight E; Townley, Ellen; Whitton, Michael; Agwu, Allison L; Smith, Christiana; Paul, Mary E; Violari, Avy; Moodley, Evette; Owor, Maxensia; Chokephaibulkit, Kulkanya; Fry, Samantha; Jao, Jennifer; Mitchell, Charles D; Buisson, Sarah; Ace, Andi; Kolobova, Irina; Bolton-Moore, Carolyn; Gaur, Aditya H

Brief Report: Postpartum Maternal Monitoring for Renal Safety Related to Tenofovir Exposure During Breastfeeding in the PROMISE 1077BF Randomized Trial

简报:PROMISE 1077BF随机试验中产后母体肾脏安全性监测与母乳喂养期间替诺福韦暴露的关系

Baltrusaitis, Kristin; Tierney, Camlin; Fowler, Mary Glenn; Owor, Maxensia; Nematadzira, Teacler G; Nyakudya, Lynette; Cassim, Haseena; de Jager, Jeanne; George, Kathleen; Heckman, Barbara; Knowles, Kevin; Browning, Renee; Siberry, George K; Taha, Taha E; Stranix-Chibanda, Lynda

Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results

IMPAACT 2019 第 48 周结果:分散型和速释型阿巴卡韦/多替拉韦/拉米夫定片剂在 HIV 感染儿童中的疗效、安全性和耐受性

Rabie, Helena; Yin, Dwight E; Ward, Shawn; Rani, Yasha; Ziemba, Lauren; Brooks, Kristina M; Cressey, Tim R; Masheto, Gaerolwe R; Cassim, Haseena; Deville, Jaime G; Ponatshego, Ponego L; Patel, Faeezah; Aurpibul, Linda; Barnabas, Shaun L; Mustich, Iris; Coletti, Anne; Heckman, Barbara; Krotje, Chelsea; Townley, Ellen; Moye, Jack; Majji, Sai; Acosta, Edward P; Ryan, Kevin; Chandasana, Hardik; Brothers, Cynthia H; Buchanan, Ann M; Flynn, Patricia M

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial

保护接触新确诊的多重耐药结核病患者的家庭成员:PHEONIx 3期临床试验研究方案

Kendall, Michelle A; Hughes, Michael D; Kim, Soyeon; Aaron, Lisa A; Naini, Linda; Suryavanshi, Nishi; Shah, N Sarita; Rouzier, Vanessa; Hafkin, Jeffrey; Sise, Thucuma; Beck, Justine; Heckman, Barbara E; Haberer, Jessica E; Harrington, Mark; Scarsi, Kimberly K; Hesseling, Anneke C; Swindells, Susan; Churchyard, Gavin J; Gupta, Amita

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

在病毒学抑制的 HIV 感染青少年中,联合使用长效注射卡博特韦和长效注射利匹韦林的安全性(IMPAACT 2017/MOCHA):一项 1/2 期、多中心、开放标签、非对照、剂量探索性研究

Moore, Carolyn Bolton; Baltrusaitis, Kristin; Best, Brookie M; Moye, John H; Townley, Ellen; Violari, Avy; Heckman, Barbara; Buisson, Sarah; Van Solingen-Ristea, Rodica M; Capparelli, Edmund V; Marzinke, Mark A; Lowenthal, Elizabeth D; Ward, Shawn; Krotje, Chelsea; Milligan, Ryan; Agwu, Allison L; Huang, Jenny; Cheung, S Y Amy; McCoig, Cynthia; Yin, Dwight E; Roberts, Gilly; Crauwels, Herta; Van Eygen, Veerle; Zabih, Sara; Masheto, Gaerolwe; Ounchanum, Pradthana; Aurpibul, Linda; Korutaro, Violet; Gaur, Aditya H

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

在病毒学抑制的 HIV 感染青少年中,口服和长效注射卡博特韦或长效注射利匹韦林的安全性和药代动力学研究(IMPAACT 2017/MOCHA):一项 1/2 期、多中心、开放标签、非对照、剂量探索性研究

Gaur, Aditya H; Capparelli, Edmund V; Calabrese, Katherine; Baltrusaitis, Kristin; Marzinke, Mark A; McCoig, Cynthia; Van Solingen-Ristea, Rodica M; Mathiba, Sisinyana Ruth; Adeyeye, Adeola; Moye, John H; Heckman, Barbara; Lowenthal, Elizabeth D; Ward, Shawn; Milligan, Ryan; Samson, Pearl; Best, Brookie M; Harrington, Conn M; Ford, Susan L; Huang, Jenny; Crauwels, Herta; Vandermeulen, Kati; Agwu, Allison L; Smith-Anderson, Christiana; Camacho-Gonzalez, Andres; Ounchanum, Pradthana; Kneebone, Jared L; Townley, Ellen; Bolton Moore, Carolyn

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study

在首批病毒学抑制的 HIV 感染青少年队列中,长效注射卡博特韦或利匹韦林的可接受性和耐受性(IMPAACT 2017/MOCHA):一项 1/2 期、多中心、开放标签、非对照剂量探索研究的二次分析

Lowenthal, Elizabeth D; Chapman, Jennifer; Ohrenschall, Rachel; Calabrese, Katherine; Baltrusaitis, Kristin; Heckman, Barbara; Yin, Dwight E; Agwu, Allison L; Harrington, Conn; Van Solingen-Ristea, Rodica M; McCoig, Cynthia C; Adeyeye, Adeola; Kneebone, Jared; Chounta, Vasiliki; Smith-Anderson, Christiana; Camacho-Gonzalez, Andres; D'Angelo, Jessica; Bearden, Allison; Crauwels, Herta; Huang, Jenny; Buisson, Sarah; Milligan, Ryan; Ward, Shawn; Bolton-Moore, Carolyn; Gaur, Aditya H

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study

在 HIV 感染儿童中,分散片和速释片阿巴卡韦、多替拉韦和拉米夫定的药代动力学、安全性和耐受性(IMPAACT 2019):一项开放标签、多中心、1/2 期剂量确认研究的第 24 周结果

Brooks, Kristina M; Kiser, Jennifer J; Ziemba, Lauren; Ward, Shawn; Rani, Yasha; Cressey, Tim R; Masheto, Gaerolwe R; Cassim, Haseena; Deville, Jaime G; Ponatshego, Ponego L; Patel, Faeezah; Aurpibul, Linda; Barnabas, Shaun L; Mustich, Iris; Coletti, Anne; Heckman, Barbara; Krotje, Chelsea; Lojacono, Mark; Yin, Dwight E; Townley, Ellen; Moye, Jack; Majji, Sai; Acosta, Edward P; Ryan, Kevin; Chandasana, Hardik; Brothers, Cynthia H; Buchanan, Ann M; Rabie, Helena; Flynn, Patricia M

Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

家庭中接触利福平耐药结核病的青少年和成人中结核分枝杆菌感染和疾病流行的相关因素

Kim, Soyeon; Hesseling, Anneke C; Wu, Xingye; Hughes, Michael D; Shah, N Sarita; Gaikwad, Sanjay; Kumarasamy, Nishi; Mitchell, Erika; Leon, Mey; Gonzales, Pedro; Badal-Faesen, Sharlaa; Lourens, Madeleine; Nerette, Sandy; Shenje, Justin; de Koker, Petra; Nedsuwan, Supalert; Mohapi, Lerato; Chakalisa, Unoda A; Mngqbisa, Rosie; Escada, Rodrigo Otávio da Silva; Ouma, Samuel; Heckman, Barbara; Naini, Linda; Gupta, Amita; Swindells, Susan; Churchyard, Gavin

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

一项随机对照试验评估了妊娠期间暴露于富马酸替诺福韦酯后母婴肾脏安全性

Baltrusaitis, Kristin; Makanani, Bonus; Tierney, Camlin; Fowler, Mary Glenn; Moodley, Dhayendre; Theron, Gerhard; Nyakudya, Lynette H; Tomu, Musunga; Fairlie, Lee; George, Kathleen; Heckman, Barbara; Knowles, Kevin; Browning, Renee; Siberry, George K; Taha, Taha E; Stranix-Chibanda, Lynda